Financial Announcements & Corporate Transactions
Xometry (XMTR) priced a $225 million offering, underscoring robust financing activity in on‐demand manufacturing.
Oddity Finance LLC (ODD) announced the upsizing and pricing of a $525 million offering of 0% exchangeable senior notes, reflecting renewed investor appetite.
Circle (CRCL)'s blockbuster IPO is fuelling talk of a new wave of public offerings in the crypto arena.
Global Partners LP (GLP) launched a cash tender offer for all outstanding 7.00% Senior Notes Due 2027, drawing keen fixed-income attention.
Daktronics, Inc. (DAKT) is set to release its fourth quarter and Fiscal 2025 financial results, a key event for assessing near-term performance (details).
Soltage (FCNCA) secures a $260 million construction and term debt facility to accelerate its clean energy deployment (read more).
Technological Innovations & Digital Transformation
Evogene (EVGN) completed its first-in-class foundation model for generative molecule design in collaboration with Google Cloud, blending biotech with cutting-edge AI.
WNS (WNS) announced a collaboration with Snowflake to accelerate AI and data modernization, driving transformation across sectors (details).
Oklo (OKLO) received a boost as the U.S. Nuclear Regulatory Commission accepted its Licensed Operator Topical Report for review, marking progress in nuclear innovation (more info).
ZenaTech (ZENA) is fast-tracked under a historic executive order, expediting its ZenaDrone subsidiary’s manufacturing and go-to-market plans for defense and commercial applications (read more).
Cisco (CSCO) is transforming security for the agentic AI era by further integrating security into network infrastructures (read more).
Leap and Xos (XOS) have partnered to power the grid with electric fleets, a pioneering move that hints at the future of sustainable energy systems (read more).
VPT (HEI) announced the appointment of Trevor Rice as the new VP of North American Sales, a strategic hire to bolster its market outreach (more info).
Biotech & Healthcare Advances
Innoviva Specialty Therapeutics (INVA) received FDA acceptance of its new drug application for zoliflodacin, a potential game-changer in infectious disease treatment.
Quest Diagnostics (DGX) is set to develop a multi-cancer stratification blood test based on MD Anderson technology, promising a breakthrough in rapid diagnostics (more info).
Zepzelca® and Tecentriq® (JAZZ) received FDA priority review as a first-line maintenance treatment for extensive-stage small cell lung cancer, advancing new oncology care avenues.
Tandem Diabetes Care (TNDM) announced an agreement with Abbott for the integration of automated insulin delivery systems with a future glucose‑ketone sensor, marking an innovative step in diabetes care (read more).
Hinge Health (HNGE) reported that fully insured medical claims analysis shows significant cost savings and a 2.4x ROI for its populations (more info).
Corporate Earnings, Market Movements & Industry Developments
Core & Main (CNM) posted record Fiscal 2025 first quarter results, setting a new benchmark in the industrial sector.
Upstart Holdings (UPST) introduced the first-ever leveraged ETFs, a disruptive innovation reshaping fintech investment strategies.
Uber (UBER) launched Level 4 autonomy trials in the UK, advancing the development of self-driving technology and next-generation mobility solutions.
AT&T (T) expanded the nation’s largest fiber network, now reaching over 30 million fiber locations and reinforcing its telecommunications leadership.
Market Indices & Strategic Developments
Travelzoo (TZOO) is set to be added to the Russell 3000 and Russell 2000 Indexes, an inclusion that could enhance its visibility among institutional investors (read more).
NioCorp (NB) has been added to the MSCI USA Index, a move that may boost its profile among global investors (more info).
Walmart Inc. (NMRK) signed a 338,000-SF lease at Jay Paul Company's iconic Tech Corners Campus in Sunnyvale, highlighting its strategic expansion in the tech hub (read more).
